source
- Lisata acquires Marea Therapeutics, securing $225M financing to advance two mid-stage drugsLisata Therapeutics completed a stock-for-stock acquisition of biotech startup Marea Therapeutics. The transaction includes a $225 million financing round led by existing backers such as Forbion,…
- Roche partners with Dualitas Therapeutics in up to $1 billion deal to screen bispecific antibodies for immune diseasesRoche has committed $36.5 million up front to biotechnology startup Dualitas Therapeutics under a research partnership that could total up to $1 billion in milestone payments and royalties. The agr…